We offer comprehensive testing as well as consultative services and a streamlined approach to laboratory medicine to meet drug discovery, diagnostic, and prognostic challenges in a timely, cost-effective manner.
Molecular Pathology Laboratory Network, Inc., (MPLN) a premiere diagnostic laboratory based in the Southeastern United States, offers an expanding selection of molecular diagnostics, flow cytometry, cytogenetic tests, and many other advanced services for oncology, pathology, women's health diagnosis, and clinical trials. MPLN practices evidence based, precise, and predictable diagnostics for individual patient management to improve patient outcome and reduce cost of care. MPLN's streamlined approach to laboratory medicine meets diagnostic and prognostic challenges in a timely, cost-effective manner.
MPLN is a leader in the implementation of patient-specific reflex testing (StrataFLEX) that strategically moves clinicians through the laboratory process, addressing each stage of patient management in a consultative, timely, and cost-effective manner. MPLN's board-certified pathologists and scientific directors provide consultative services in oncology, hematopathology, and women's health.
MPLN is dedicated to providing superior diagnostic services to our clients in pathology groups, hospitals, medical laboratories, and physician groups nationwide. With a patient-focused approach, we honor an obligation to provide:
Geneuity Clinical Research Services (CRS) is MPLN's provider of molecular and cellular testing for preclinical through phase III and post market surveillance as well as assay and companion diagnostic development and validation.
MPLN can assist oncology and pathology groups, clinical laboratories, and hospitals in readiness for health care changes.
Geneuity CRS also can assist both medical device companies and drug discovery by providing services and access to high complexity testing, platform, and assay validation of biomarkers or companion diagnostics, patient screening for clinical trial selection, and recuitment and clinical trial testing in a CLIA regulated, CAP accredited, and GxP compliant medical laboratory setting.